Images List Premium Download Classic

Staurosporin

Staurosporin-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
NEW Liposomal drug encapsulation
The Regents Of The University Of California
June 22, 2017 - N°20170173041

Provided herein are compositions methods of using liposomally encapsulated therapeutic drugs, such as staurosporine. Further provided herein are methods of using the liposome compositions to treat a cancer.
Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemias
The Regents Of The University Of California
June 30, 2016 - N°20160184319

The present invention relates to a method of treating a warm-blooded animal, especially a human, having mixed lineage leukemia (mll rearranged all) comprising administering to said animal a therapeutically effective amount of a staurosporine derivative, especially pkc412 or a pharmaceutically acceptable salt thereof, alone or in combination with further therapeutic measures, for example, those defined herein; to the use of ...
Plymorephous forms iii and iv of n-benzoyl - staurosporine
The Regents Of The University Of California
December 24, 2015 - N°20150368268

The present invention relates to a crystalline form iii and a crystalline form iv of n-benzoyl staurosporine.
Staurosporin Patent Pack
Download + patent application PDFs
Staurosporin Patent Applications
Download + Staurosporin-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Staurosporin-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemias
The Regents Of The University Of California
February 27, 2014 - N°20140057897

The present invention relates to a method of treating a warm-blooded animal, especially a human, having mixed lineage leukemia (mll rearranged all) comprising administering to said animal a therapeutically effective amount of a staurosporine derivative, especially pkc412 or a pharmaceutically acceptable salt thereof, alone or in combination with further therapeutic measures, for example, those defined herein; to the use of ...
Spontaneously dispersible n-benzoyl staurosporine compositions
The Regents Of The University Of California
February 27, 2014 - N°20140056974

Spontaneously dispersible n-benzoyl-staurosporine compositions are discussed for oral administration having high bioavailability levels and reduced variability of bioavailability levels of n-benzoyl-staurosporine, as well as their preparation and use in medical treatment.
Staurosporin Patent Pack
Download + patent application PDFs
Staurosporin Patent Applications
Download + Staurosporin-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Staurosporin-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Staurosporin Patent Pack
Download + patent application PDFs
Staurosporin Patent Applications
Download + Staurosporin-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Staurosporin-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Loading